Legal updates in the Russian Life Sciences industry for the first half of 2023

Legal updates in the Russian Life Sciences industry for the first half of 2023

17 July 2023

We are glad to present you with an overview of the Russian regulations in the sphere of pharmaceuticals and life sciences for the 1st half of 2023.

There are several digital initiatives in the healthcare sector, such as pilot launch of online sale of Rx medicines and the extension of experiment with track-and-trace system for medical devices. We see that the regulators are willing to take step forward and extend the period of registration of medical devices under national rules, but in other sectors they are taking closer look on current requirements and may apply stricter approach (e.g., implement additional requirements for food additives). All in all, the pharma industry and its regulatory framework is relatively stable now.

You can read the Guide by clicking here:

We hope that the information provided herein will be useful for you.

If any of your colleagues would also like to receive our newsletters, please send them the link to complete a Subscription Form .
Learn more about our practices:
Healthcare and Pharmaceutical Industry

Note: Please be aware that all information provided in this letter was taken from open sources. Neither ALRUD Law Firm, nor the author of this letter bear any liability for consequences of any decisions made in reliance upon this information.

If you have any questions, please, do not hesitate to contact us.

ALRUD Law Firm

Skakovaya str., 17, bld. 2, 6th fl., Moscow, Russia, 125040
Т: +7 495 234 96 92, Т: +7 495 926 16 48,
We use cookies to offer better performance of the website and fulfill some other purposes specified in the Privacy Policy. By way of ticking the box you provide your consent to use of cookies. Otherwise, we will only use technical cookies, which are necessary for proper functioning of the website.